CAR-T Platform
Healthy T cells and malignant T cells share the same surface proteins (target antigens)
Deletion of the target antigen from the surface of the engineered CAR-T cell, that is derived from a healthy donor T cell, prevents self-killing (fratricide) while ensuring CAR-T cells kill malignant T cells
Deletion of the T-cell receptor (TCR) enables the use of T cells from healthy donors without the risk of life-threatening Graft vs. Host Disease (GvHD)
Next in our story
Copyright © 2025 Wugen. All Rights Reserved.
Privacy Notice
a COGNEO design